Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 615 | 627 | 606 | 849 | 422 |
| Cost of Goods | 250 | 164 | 109 | 26 | 3 |
| Gross Profit | 365 | 463 | 496 | 823 | 420 |
| Operating Expenses | 1,242 | 1,285 | 1,997 | 1,469 | 700 |
| Operating Income | -628 | -658 | -1,392 | -620 | -278 |
| Interest Expense | 2 | 117 | 258 | 19 | 1 |
| Other Income | 10 | 32 | 346 | 1 | 0 |
| Pre-tax Income | -619 | -743 | -1,303 | -638 | -279 |
| Income Tax | N/A | N/A | N/A | -330 | 1,595 |
| Net Income Continuous | -619 | -743 | -1,303 | -308 | -1,874 |
| Net Income Discontinuous | N/A | N/A | N/A | 524 | -2,537 |
| Net Income | $-619 | $-743 | $-1,303 | $216 | $-4,410 |
| EPS Basic Total Ops | -0.70 | -0.84 | -2.10 | 0.28 | -5.04 |
| EPS Basic Continuous Ops | -0.70 | -0.84 | -1.47 | -0.28 | -2.10 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.56 | -2.94 |
| EPS Diluted Total Ops | -0.70 | -0.84 | -2.10 | 0.28 | -5.04 |
| EPS Diluted Continuous Ops | -0.70 | -0.84 | -1.47 | -0.28 | -2.10 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.56 | -2.94 |
| EBITDA(a) | $-561 | $-492 | $-1,140 | $-451 | $-267 |